AbstractObjectivesThe objective of this study was to explore the integration of Traditional Korean Medicine (TKM) into existing clinical pathways for the treatment of gastric cancer. focusing on enhancing treatment outcomes and improving patient quality of life.
MethodsEmploying a prospective observational design, the study targeted adults aged 20–75 diagnosed with gastric cancer. It assessed the TKM pathway's impact on quality of life, tumor markers, complete blood count test values, and patient satisfaction, and monitored adverse reactions to evaluate effectiveness and safety.
ResultsThe study demonstrated improved quality of life(QOL), as indicated by increased Karnofsky Performance Scale(KPS) scores Mean Difference(MD)=20.37, and better quality of life (MD=19.79) assessments. Blood test results showed notable enhancements in immune function markers such as Neutrophil (MD=−7.34%) and Lymphocyte (6.80%), and Erythrocyte Sedimentation Rate (ESR)(MD=−11.05mm/hr). Both patient and medical staff satisfaction (MD=0.33) improved, although changes in tumor markers were not statistically significant.
ConclusionsThe integration of TKM into the treatment of gastric cancer can significantly improve patient quality of life and satisfaction. To further substantiate these results, developing and implementing more critical pathways across varied clinical settings, along with larger-scaled studies, are essential.
참고문헌1. 2020 Cancer Registry Statistics and 2014–2018 Regional Cancer Incidence Statistics press release. National Cancer Center;2022. 출처: URL: https://ncc.re.kr
2. Yang, Lei, et al. (2020). Gastric cancer: Epidemiology, risk factors and prevention strategies. Chinese Journal of Cancer Research, 32(6), 695. https://doi.org/10.21147/j.issn.1000-9604.2020.06.03
![]() ![]() ![]() 3. Joo, Kang Mee, et al. (2023). “Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2020.” Cancer Research and Treatment. Official Journal of Korean Cancer Association, 55(2), 385. https://doi.org/10.4143/crt.2023.447
4. Park, SH, & Lee, SI. (2012). Recent Advances in Chemotherapy of Gastric Cancer. The Korean Journal of Medicine, 82(4), 417-26. DOI: https://doi.org/10.3904/kjm.2012.82.4.417
![]() 5. 설은미 . (2021). 위암 수술 환자의 건강관련 삶의 질 구조모형. Doctoral dissertation. 서울대학교;대학원.
6. Zhao, P, & Lei, XM. (2013). Progress in causes of cancer-related fatigue[J]. Journal of Modern Oncology, 21(4), 894-898. https://doi.org/10.3969/j.issn.1672-4992.2013.04.77
7. Oh, IO, Chang, TI, & Kim, HJ. (2022). Status of the Development and Utilization of Critical Pathways. Quality Improvement in Health Care, 28(1), 2-13. DOI: https://doi.org/10.14371/QIH.2022.28.1.2
8. Chang, SB, Lee, TW, & Kim, S. (2006). A study of complementary and alternative medicine used by cancer patients in Korea. J Korean Acad Adult Nurs, 92-101.
9. Hwang, CY. (1997). Bibliographic Study on the Therapy of Gastric Cancer by Intergrated Oriental and Western Medicine. The Journal of Wonkwang Oriental Medicine, 7(1), 10-8.
10. Jung, JH, Seo, JC, Kwak, MA, & Sohn, KC. (2014). Literature Review on Traditional Chinese Medicine Treatment of Gastric Cancer. J Int Korean Med, 35(3), 332-42.
11. Konishi, T, Noye, T, Furujima, K, & Harihara, Y. (2001). Significance of critical path for gastric cancer: Gastrointestinal diseases and social medicine. Nippon Shokakibyo Gakkai Zasshi;, 98(12), 1341-8.
12. Hong, MN, Shim, SH, & Yoon, SH. (2017). Development and Validity Test on Preliminary Critical Pathway of Integrative Medicine for Lung Cancer Patients Treated with Chemotherapy. J Int Korean Med, 38(6), 917-29. https://doi.org/10.22246/jikm.2017.38.6.917
13. 김기연, . (1996). 관상동맥 우회술 환자를 위한 Critical pathway 개발. 연세대학교 대학원 간호 학과 석사논문, 28(1), 117-131.
14. 김효린, , et al. (2016). 위암 치료에 대한 한의 임 상 가이드라인. 대한한방내과학회지 제, 37(1),
15. Park SJ, Yoo HS, Cho CK, et al. (2023). The Korean Association of Traditional Oncology. Clinical Practice Guideline of Korean Medicine for Gastric Cancer Panmuneducation. National Institute for Korean Medicine Development;p. 1-177.
16. Kwon, HK, Kim, JS, & Yu, HS. (2009). Review for the Status of Cancer Complementary and Alternative Medicine in the World. J Korean Tradit Oncol, 14(1), 1-11.
17. Kim, MH, Kang, PS, & Lee, KS. (2007). Utilization of Complementary and Alternative Medicine of Cancer Patient in Korea. J Agr Med Community Health, 32(3), 155-67.
![]() 18. Yoo, SH, Yoo, HS, Cho, CK, & Lee, YW. (2007). A Case Report for Recurred Squeamous Cell Lung Carcinoma Treated with Hang-An-Dan: 7-year follow-up. Korean J Int Korean Med, 28(2), 385-90.
19. Choi, JY, Lee, JY, & Kim, ES, et al. (2008). Clinical data analysis of 106 breast cancer patients who received oriental medical treatment. The Journal of Korean Obstetrics and Gynecology, 21(4), 228-236.
20. 고금영, 박소정, et al. (2023). ‘표준치료를 받은 폐암 환자의 한방병원 입원 임상경로’개발 및 적 용. J Physiol & Pathol Korean Med, 37(6), 178-184. http://dx.doi.org/10.15188/kjopp.2023.12.37.6.178
21. 송교영, 김승남 박조현. (2005). 위암수술 환 자에서의 critical pathway 의 개발과 적용. 대한 위암학회지, 5(2), 95-100.
|
|